USPTO serial 79338308
CYTOSIMILARS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 26, 2023
- Examiner
- SEGAL, MOLLY DANIELA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CYTOSIMILARS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Sullivan
Brian P. Sullivan Thomas E. Lees, LLC90 Rhoads Center DriveDayton, OH 45458UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines, pharmaceutical preparations and biological preparations for human and veterinary purposes, namely, for use in connection with stem cell differentiations, stem cell therapies, cancer treatments, autoimmune disease treatments and allergy treatments for humans and animals | ACTIVE | — |
| 042 | Biological research and analysis; Research and development of new products for others; Research and development of new products for use in stem cell differentiation for others; Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of stem cell differentiation; Scientific research for medical purpose relating to stem cell differentiation; Pharmaceutical research and development; Research in the field of medicine; Research in the field of medicine in the area of stem cell differentiation; Research on the subject of pharmaceuticals; Scientific research in the field of pharmacy; Research and development in the pharmaceutical and biotechnology fields; Consultancy relating to pharmaceutical research and development; Consultancy relating to research and development in the field of therapeutics; Provision of information and data relating to medical and veterinary research and development; Provision of information and data relating to medical and veterinary research and development in the field of stem cell differentiation; Scientific laboratory services for analytical testing; Medical laboratory services for analytical testing relating to stem cell differentiation; Medical research laboratory services; Medical research laboratory services in the field of stem cell differentiation | ACTIVE | — |
| 044 | Alternative medicine services; health counselling; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of samples of human cells taken from patients; medical laboratory services for the analysis of samples of stem cells taken from patients; medical diagnostic services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cytosimilars GmbH
- Other trademarks owned by Cytosimilars GmbH
- Other trademarks owned by Cytosimilars GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CYTOSIMILARS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 22, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 3, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 3, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 26, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 9, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 20, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 21, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 21, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 21, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 2, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 16, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 3, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 28, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 28, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 28, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 28, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 27, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 14, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |